This post was originally published on Medscape
You will shortly be re-directed to the publisher's website
Glucagon-like peptide 1 receptor agonist therapy over a 12-month period is safe and effective in treating weight regain following bariatric surgery, a Swiss real-world study reveals.
Medscape News UK